Forecast Sales for Human and Animal Health
ClearikonFLEX™ is designed for frontline healthcare professionals such as in hospitals, clinics, and home health organizations. Our commercialization strategy will leverage strategic partners to expand sales and distribution channels to hospital, home health, military, and retail customers.
We have also develped ClearikonFLEX™ products for Animal Health. We currently sell equine bandages, disinfection, and topical wound products. Our products are engineered for professional use by veterinarians across clinical, hospital, and farm settings. Clearikon's market strategy is to support our veterinay sales representative to build our business with high-volume ecomerce sales to retail and veterinary customers.
•Medical Device Contract Manufacturing for 2026 pilot - July - September 2026
•Simplified Class 1 Bandage FDA Registration - May 2026 - Complete
•CMS Reimbursement application - July 1 -2026
•Pilot Study and Sales Release - Q3 & Q4 2026
•Distributor sales agreements with hospitals, clinics, and home healthcare Q2-2027
•Veterinary sales agreement - April 2026 - Complete
• Veterinary products initial sales - June 2026
Initial Raise -$300K for 2026 Milestones.
Total Raise - $1.7M for 2027 thru 2030 Milestones
Shareholders include founders, friends, and a veterinarian
Current shareholders own common stock
Clear Care Products, Inc.
Delaware C Corporation - Incorporated October 2016